ArticleAmerican journal of cancer research2026
Retrospective study on maintenance therapy with PD-1 inhibitor combined with S-1 or capecitabine after first-line treatment for recurrent or metastatic nasopharyngeal carcinoma.
Hao Yuan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.